Jamal Wright v. Touro Infirmary

JAMAL WRIGHT ET AL * NO. 2021-C-0324 VERSUS *

COURT OF APPEAL TOURO INFIRMARY ET AL *

FOURTH CIRCUIT

*

STATE OF LOUISIANA

*******

APPLICATION FOR WRITS DIRECTED TO CIVIL DISTRICT COURT, ORLEANS PARISH

NO. 2018-01903, DIVISION “E” Honorable Omar Mason, Judge ****** Judge Rosemary Ledet ******

(Court composed of Judge Terri F. Love, Judge Edwin A. Lombard, Judge Rosemary Ledet) Benjamin Biller 1100 Poydras Street, Suite 2700 New Orleans, Louisiana 70163

COUNSEL FOR RELATORS Danatus King 2475 Canal Street, Suite 308 New Orleans, Louisiana 70119

COUNSEL FOR RESPONDENT

WRIT GRANTED IN PART AND DENIED IN

PART; JUDGMENT RENDERED JULY 7, 2021

This is a medical malpractice case. The Relators—Touro Infirmary and RML

Kimberly Guidry, R.N.—seek review of the trial court’s April 9, 2021 judgment TFL denying their re-urged peremptory exception of prescription.1 The narrow issue EAL presented here is whether the wrongful death and survival action claims asserted by the Respondent—Jamal Wright (“Mr. Wright”) on behalf of his minor child, Janaya Wright (“Janaya”)—are prescribed. For the reasons that follow, we grant the writ as to the wrongful death action claim, but deny the writ as to the survival action claim.

Factual and Procedural Background The medical malpractice claims asserted here arise from medical treatment provided to Nicole Phillips (“Ms. Phillips”) following the birth of her child,

Janaya.2 Janaya was born on October 31, 2014. On the following day, Ms. Phillips became unresponsive, went into a coma, and sustained a brain injury. On June 4, 2016, Ms. Phillips died.

The relevant procedural time line in this case is as follows:  January 22, 2015: Ms. Phillips was interdicted and her parents—Donald Phillips, Sr., and Aubranell Phillips (“Grandparents”)—were appointed as her curator and undercurator, respectively;  June 2, 2015: An interim consent judgment was rendered, granting joint custody of Janaya to Grandparents and Mr. Wright, but designating Mr. Wright as the domiciliary parent;  October 7, 2015: An initial request for a medical review panel was filed, naming Ms. Phillips as the claimant;  October 15, 2015: An amended request for medical review panel was filed, substituting Grandparents, in their respective capacities as curator and undercurator, as the claimants;  February 7, 2017: A second amended request for medical review panel was filed, clarifying that Ms. Phillips had died on June 4, 2016; that she was survived by her parents (Grandparents) and a minor child, Janaya; and that the Grandparents had legal custody of Janaya;  June 21, 2017: Grandparents’ attorney sent a letter to the Division of Administration, advising that upon Ms. Phillips’ death, her right of action passed to Janaya and that Grandparents “no longer possess a right of action to pursue these claims. That right is now vested in Jamal Wright, the father of the minor child, on his daughter’s behalf”;  July 20, 2017: Mr. Wright’s attorney sent a letter of representation to the Division of Administration, advising that “[Mr] Wright has hired our firm to represent him on behalf of his minor daughter, Janaya Wright, in the above reference matter”; and  December 11, 2017: Mr. Wright, acting on behalf of Janaya, filed a request with the Division of Administration to have Janaya, as Ms. Phillips’s sole heir, substituted for Ms. Phillips as claimant in this matter; included with this request was a copy of Janaya’s birth certificate.

Relators’ initial exception of prescription, which was filed while the medical review panel proceeding was pending, was denied in January 2018. Thereafter, the medical review panel issued its decision, and Respondent filed this suit. In May 2019, the Louisiana Supreme Court issued its decision in Guffey v. Lexington House, LLC, 18-1568 (La. 5/8/19), 283 So.3d 1001.3 Based on the Guffey case, Relators re-urged their prescription exception.

Relators’ argument has four parts: (i) Janaya, as Ms. Phillips’ only surviving heir, had the right of action to bring survival and wrongful death action claims; (ii) Janaya is a minor who lacks procedural capacity and, thus, her father, Mr. Wright, had to assert her claims within one year of Ms. Phillips’ death;4 (iii) Grandparents did not have the right of action or procedural capacity to assert a claim, thus, their February 7, 2017 medical review panel request did not suspend prescription, as held in Guffey; and (iv) because prescription was never suspended after Ms. Phillips’ death, Janaya’s claims, asserted by Mr. Wright, are prescribed.

The trial court denied Relators’ re-urged exception. In so doing, the trial court reasoned that because Grandparents had legal custody of Janaya, albeit as non-domiciliary parents, their February 7, 2017 request for a medical review panel “meets the requirements of the wrongful death and survival actions interruption of prescription.” This writ followed.

Standard of Review and Governing Law This court has summarized the standard of review of a trial court's judgment granting or denying an exception of prescription as follows:

When no evidence is introduced, the judgment is reviewed simply to determine whether the trial court's decision was legally correct. A de novo standard of review applies. In this context, the exception of prescription must be decided on the facts alleged in the petition, which are accepted as true.

When evidence is introduced, the trial court's factual findings on the issue of prescription generally are reviewed under the manifestly erroneous-clearly wrong standard of review. When evidence is introduced but the case involves no dispute regarding material facts, only the determination of a legal issue, an appellate court must review the issue de novo, giving no deference to the trial court's legal determination. ...

Ordinarily, the defendant—the party asserting a peremptory exception of prescription—bears the burden of proof. When the plaintiff's claim is prescribed on the face of the petition, however, the burden shifts to the plaintiff to establish that his or her claim has not prescribed.

Wells Fargo Fin. Louisiana, Inc. v. Galloway, 17-0413, pp. 8-9 (La. App. 4 Cir. 11/15/17), 231 So. 3d 793, 800 (citations, quotation marks, and alterations omitted).

Medical malpractice claims are subject to a special prescriptive period codified in La. R.S. 9:5628(A), which provides:

No action for damages for injury or death against any physician . . . whether based upon tort, or breach of contract, or otherwise, arising out of patient care shall be brought unless filed within one year from the date of the alleged act, omission, or neglect, or within one year from the date of discovery of the alleged act, omission, or neglect; however, even as to claims filed within one year from the date of such discovery, in all events such claims shall be filed at the latest within a period of three years from the date of the alleged act, omission, or neglect.

The reference in La. R.S. 9:5628 to actions for death “applies solely to survival actions as they are derivative of the malpractice victim’s action.” Taylor v. Giddens, 618 So.2d 834, 841 (La. 1993). In contrast, wrongful death actions are not derivative because they are “not dependent upon the victim having a viable malpractice action.” Id. As a result, wrongful death actions are governed by the one-year tort prescription period set forth in La. C.C. art. 3492. Id. Wrongful death claims, nonetheless, “continue to be governed and procedurally controlled by the provisions of the [Medical Malpractice] Act.” Taylor, 618 So.2d at 841. Because wrongful death and survival action claims are separate and distinct, “the filing of the survival action does not interrupt prescription for the wrongful death action.” 12 LA. CIV. L. TREATISE, TORT LAW, §5:20 (2d ed.).

Explaining the special prescription rules regarding medical malpractice actions, this court has observed:

Despite the one-year prescriptive period, “medical malpractice lawsuits are virtually never actually filed in courts of competent jurisdiction within one year of the alleged act of malpractice.” In re Noe, 05-2275, p. 8 (La. 5/22/07), 958 So.2d 617, 622 (Calogero, C.J., concurring in part, dissenting in part). This is because “[f]iling a complaint with the review panel is a mandatory initial step in a malpractice claim and a requirement before filing suit ‘in any court.’ ” Nathan v. Touro Infirmary, 512 So.2d 352, 353 (La. 1987).

Acknowledging this initial step, the Louisiana Legislature has expressly “provided that the filing of the request for a review of a claim suspend[s] the running of prescription, ... just as the filing of a suit in a competent jurisdiction suspends the running of prescription.” Id. at 354.

Med. Review Complaint by Downing, 18-1027, p. 7 (La. App. 4 Cir. 5/8/19); 272 So.3d 55, 59-60.

Although the filing of a request for a medical review panel is equivalent to the filing of a suit for purposes of interrupting prescription, the party filing the request must be a proper “claimant” under La. R.S. 40:1231.1(A)(4).5 The Supreme Court, in Guffey, construed the term “claimant” to mean those with a right of action under La. C.C. arts. 2315.1 or 2315.2.

Discussion Here, Relators contend that since Grandparents were not proper party claimants under La. R.S. 40:1231.1(A)(4), their February 7, 2017 request for a medical review panel did not serve to interrupt prescription. In support, Relators cite the Guffey case. We find this argument persuasive as to Respondent’s wrongful death action claim, which did not arise until Ms. Phillips’ death, but not as to Respondent’s survival action claim.

In finding Respondent’s claim was timely asserted, the trial court relied on Grandparents’ February 7, 2017 request for a medical review panel, which was filed within one year of Ms. Phillips’ death. Mr. Wright, on Janaya’s behalf, failed to timely assert a claim within one year of Ms. Phillips’ death. Grandparents’ February 7, 2017 request for a medical review panel did not interrupt prescription because Grandparents lacked a right of action to file a wrongful death action claim. The Guffey case, as Relators contend, dictates a finding that Janaya’s wrongful death action claim is prescribed. For these reasons, the trial court erred in denying Relators’ prescription exception as to the wrongful death action claim.

As to Respondents’ survival action claim, however, a different analysis is required. Taylor, 618 So.2d at 841 (observing that although survival and wrongful death action claims arise from the same tortious act, they are separate and distinct). Before Ms. Phillips died, a timely request for a medical review panel was filed on her behalf. Ms. Phillips’ request was filed by her parents—Grandparents—in their respective capacities as curator and undercurator. Because Ms. Phillips timely filed a request for a medical review panel before she died, the one-year prescriptive period does not apply to Janaya’s right of substitution as to the survival action claim. See Nathan v. Touro Infirmary, 512 So.2d 352, 355 (La. 1987) (observing that once an action has been instituted timely, “the one year prescriptive period . . . no longer applies to the survival action, but rather the nonabatement [La. C.C.P. art. 426-28] and substitution [La. C.C.P. art. 801] provisions of the Code of Civil Procedure control”).6

On December 11, 2017, Mr. Wright properly substituted Janaya in Ms. Phillips’ place as to the survival action claim. As Respondent points out, Ms. Phillips’ action had not been abandoned before Janaya’s substitution. For these reasons, the trial court did not err in denying Relators’ prescription exception as to the survival action claim.

Conclusion Accordingly, Relators’ writ application is granted in part; and the trial court’s April 9, 2021 judgment is reversed insofar as it denied Relators’ exception of prescription as to the wrongful death action claim. Judgment is rendered granting Relators’ exception of prescription as to the wrongful death action claim and dismissing that claim. In all other respects, Relators’ writ is denied.

WRIT GRANTED IN PART AND DENIED IN PART; JUDGMENT RENDERED